Table 1 Experimental treatment groups
Skin-primed HTm model | Reagent | Treatment |
|---|---|---|
Control | Saline | Anti-LFA-1 (0.1 mg) and anti-CD154 (0.25 mg/d) were administered i.p. on days 0, 2, and 4 after transplantation. TD (100 mg/kg/day) was administered i.g. on days 0–10 after transplantation, the same as the saline. |
mAbs | anti-LFA-1 and anti-CD154 | |
TD | TD | |
TD + mAbs | TD, anti-LFA-1, and anti-CD154 |